These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 37734566

  • 1. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.
    Tang J, Li J, Lian J, Huang Y, Zhang Y, Lu Y, Zhong G, Wang Y, Zhang Z, Bai X, Fang M, Wu L, Shen H, Wu J, Wang Y, Zhang L, Zhang H.
    J Adv Res; 2024 Jul; 61():239-251. PubMed ID: 37734566
    [Abstract] [Full Text] [Related]

  • 2. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y, Zhang H, Chen C, Liu L, Ding T, Wang Y, Ma D, Ling X, Chen X, Li J, Guansheng, Zhong, Ru G, Zhang L, Tang J.
    Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
    [Abstract] [Full Text] [Related]

  • 3. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H, Li Z, Chen J, Hu X.
    J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
    [Abstract] [Full Text] [Related]

  • 4. Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy.
    Zheng B, Qian F, Wang X, Wang Y, Zhou B, Fang L.
    J Exp Clin Cancer Res; 2024 Jun 26; 43(1):177. PubMed ID: 38926803
    [Abstract] [Full Text] [Related]

  • 5. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim H, Yin T, Fan S, Shen Q.
    Oncogene; 2018 Sep 26; 37(39):5292-5304. PubMed ID: 29855616
    [Abstract] [Full Text] [Related]

  • 6. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D, Jia H, Zhang Z, Li S.
    Bioorg Chem; 2021 Apr 26; 109():104722. PubMed ID: 33618253
    [Abstract] [Full Text] [Related]

  • 7. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
    Shao Z, Ma X, Zhang Y, Sun Y, Lv W, He K, Xia R, Wang P, Gao X.
    Mol Carcinog; 2020 May 26; 59(5):533-544. PubMed ID: 32181526
    [Abstract] [Full Text] [Related]

  • 8. Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer.
    Jian Y, Huang X, Fang L, Wang M, Liu Q, Xu H, Kong L, Chen X, Ouyang Y, Wang X, Wei W, Song L.
    J Exp Clin Cancer Res; 2021 Feb 04; 40(1):56. PubMed ID: 33541412
    [Abstract] [Full Text] [Related]

  • 9. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
    Wang J, Fang Y, Liu T.
    Biomed Res Int; 2020 Feb 04; 2020():4027627. PubMed ID: 32051827
    [Abstract] [Full Text] [Related]

  • 10. VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer.
    Song H, Luo Q, Deng X, Ji C, Li D, Munankarmy A, Jian W, Zhao J, Fang L.
    Exp Mol Med; 2019 Nov 20; 51(11):1-13. PubMed ID: 31748508
    [Abstract] [Full Text] [Related]

  • 11. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
    Wang C, Xu J, Fu H, Zhang Y, Zhang X, Yang D, Zhu Z, Wei Z, Hu Z, Yan R, Cai Q.
    J Cell Mol Med; 2018 Oct 20; 22(10):5020-5028. PubMed ID: 30079558
    [Abstract] [Full Text] [Related]

  • 12. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
    Satriyo PB, Su CM, Ong JR, Huang WC, Fong IH, Lin CC, Aryandono T, Haryana SM, Deng L, Huang CC, Tzeng YM, Chao TY, Liu HW, Yeh CT.
    Toxicol Appl Pharmacol; 2021 Jul 01; 422():115493. PubMed ID: 33727089
    [Abstract] [Full Text] [Related]

  • 13. Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis.
    Meng Q, Wang L, Lv Y, Wu J, Shi W.
    Cancer Biother Radiopharm; 2021 Feb 01; 36(1):23-35. PubMed ID: 32319789
    [Abstract] [Full Text] [Related]

  • 14. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
    Jin XX, Mei YN, Shen Z, Zhu JF, Xing SH, Yang HM, Liang G, Zheng XH.
    Phytomedicine; 2022 Jul 01; 101():154087. PubMed ID: 35429924
    [Abstract] [Full Text] [Related]

  • 15. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
    Sriramulu S, Thoidingjam S, Chen WM, Hassan O, Siddiqui F, Brown SL, Movsas B, Green MD, Davis AJ, Speers C, Walker E, Nyati S.
    J Exp Clin Cancer Res; 2024 Jun 11; 43(1):163. PubMed ID: 38863037
    [Abstract] [Full Text] [Related]

  • 16. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
    Liu Q, Cao Y, Wei X, Dong H, Cui M, Guan S, Liu B, Wang X, Xing P.
    Cell Death Dis; 2023 Dec 07; 14(12):803. PubMed ID: 38062011
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
    Cai Y, Gu WT, Cheng K, Jia PF, Li F, Wang M, Zhang WF, Qiu JT, Wu ZB, Zhao WG.
    Biochem Biophys Res Commun; 2021 Apr 23; 550():134-141. PubMed ID: 33691199
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
    Thomas AL, Lind H, Hong A, Dokic D, Oppat K, Rosenthal E, Guo A, Thomas A, Hamden R, Jeruss JS.
    Cell Cycle; 2017 Aug 03; 16(15):1453-1464. PubMed ID: 28678584
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
    Zhang H, Zheng J, Fu Y, Ling J, Liu Z, Lin X, Dong X, Sun Y, Tan T, Guo Z, Xie G.
    Breast Cancer Res Treat; 2023 Apr 03; 198(3):437-446. PubMed ID: 36797433
    [Abstract] [Full Text] [Related]

  • 20. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ, Liu YY, Li XG, Lian B, Lu XX, Jin X, Shao ZM, Hu X, Di GH, Jiang YZ.
    Cancer Res; 2021 Nov 01; 81(21):5491-5505. PubMed ID: 34408002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.